Center for Molecular Prediction of Inflammatory Bowel Disease (PREDICT)

Led by principal investigator, professor, and center director Tine Jess

Center for Molecular Prediction of Inflammatory Bowel Disease (PREDICT) is a national research center of excellence where researchers develop strategies for personalised medicine for patients with inflammatory bowel diseases. Inflammatory bowel diseases (IBD) are chronic and debilitating disorders that affect millions of people worldwide.

The researchers use Danish National Genome Center's supercomputer to store and analyze extensive datasets, including genetic data, obtained by linking biological information from samples from Denmark's National Biobank and regional biobanks with data from Danish health registries, as well as nationally and regionally collected cohorts.

It is essential that the country's most important initiatives, such as the development and especially the implementation of personalised medicine, are centralized. Despite Denmark being a relatively small country, we tend to work in many silos, which is not beneficial for progress in any area, says principal investigator, professor, and center director Tine Jess.

By comparing data with information on how patients' diseases have evolved over time, PREDICT hopes to discover new insights into what causes IBD, why it progresses differently in different individuals, and why people respond differently to treatment.

Learn more about PREDICT